For Investors

Invest in Transforming Global Healthcare

Join a mission of transforming global healthcare through healthtech that makes care more accessible and effective. ABGD partners with founders building sustainable, high-impact ventures and helps them expand from emerging markets into developed economies. Our approach combines domain depth, operational discipline, and a focus on measurable outcomes that create lasting enterprise value.

Your Opportunity

  • Get exclusive access to top innovations through our deep industry relationships and an expansive, proprietary network.
  • Proven framework and playbook to help ventures expand seamlessly across regions with measurable success metrics.
  • Deep regulatory knowledge across various international markets especially the US, EU, UK, GCC, and Africa to accelerate expansion
  • Team of founders and operators to offer practical, hands-on guidance built on decades of scaling experience.
  • Our global approach consistently unlocks outsized returns by turning early-stage investments into high-value outcomes.
Explore Opportunities
Meet Our Advisors

Your Opportunity as a Limited Partner

Unique Access

Proprietary deal flow and India's top founders through strategic partnerships with incubators, academia, and leading medical institutions.

Strong Multiplier

From cross-border scaling and proven expertise in guiding startups into regulated, high ARPU global markets.

De-risked Innovation

Achieved through systematic market validation, backed by policy support and precise mapping of healthcare pain points to scalable tech innovations.

Impact + Outsized Returns

Exceptional capital efficiency by entering at India- stage valuations while capturing the full upside of global market potential.

Early Portfolio Success

Current investments including Dozee, DocsTribe, Empaithy, and Respyr have significant traction and embedded appreciation.

Co-investment Opportunities

Access to exclusive co-investment opportunities alongside the fund.

Attractive Blended Returns

Healthtech venture IRRs are trending, outperforming traditional healthcare PE.

Policy Support

CMS, NIH, & ONC initiatives (TEFCA, VBID) provide reimbursement certainty & regulatory tailwinds.  Operator-led diligence frameworks reduce investor risk.

Exit Momentum

500+ expected digital-health M&A events and 50+ IPO-scale opportunities projected by 2030.